Implementation Activities in Smoke-Free Public Housing: The Massachusetts Experience.

health policy implementation low income populations public housing secondhand smoke smoke-free policy tobacco control

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
21 12 2022
Historique:
received: 06 10 2022
revised: 12 12 2022
accepted: 14 12 2022
entrez: 8 1 2023
pubmed: 9 1 2023
medline: 11 1 2023
Statut: epublish

Résumé

A 2018 rule requiring federally-subsidized public housing authorities (PHAs) in the United States to adopt smoke-free policies (SFPs) has sparked interest in how housing agencies can best implement SFPs. However, to date, there is little quantitative data on the implementation of SFPs in public housing. Massachusetts PHAs were among the pioneers of SFPs in public housing, and many had instituted SFPs voluntarily prior to the federal rule. The aim of this study was to examine the adoption, implementation, and outcomes of SFPs instituted in Massachusetts PHAs prior to 2018 using a survey conducted that year. The survey asked if PHAs had SFPs and, if so, what activities were used to implement them: providing information sessions, offering treatment or referral for smoking cessation, soliciting resident input, training staff, partnering with outside groups, using a toolkit, and/or providing outdoor smoking areas. We used multivariable regression to investigate associations between implementation activities and respondent-reported policy outcomes (resident support, complaints about neighbors' smoking, and the number of violations reported per year). Of 238 Massachusetts PHAs, 218 (91%) completed the survey and 161 had an SFP prior to 2018. Common implementation activities were offering smoking cessation treatment/referral (89%) and information sessions for residents (85%). Information sessions for residents were associated with higher resident support (adjusted odds ratio [AOR] 4.3; 95%CI 1.2-15.3). Training staff (AOR 6.3, 95%CI 1.2-31.8) and engaging in ≥5 implementation activities (AOR 4.1, 95%CI 1.2-14.1) were associated with fewer smoking-related complaints. Utilization of multiple implementation activities, especially ones that informed residents and trained PHA staff, was associated with more favorable policy outcomes. We identified five groups of PHAs that shared distinct patterns of SFP implementation activities. Our findings, documenting implementation activities and their associations with SFP outcomes among the early adopters of SPFs in Massachusetts public housing, can help inform best practices for the future implementation of SFPs in multiunit housing.

Identifiants

pubmed: 36612394
pii: ijerph20010078
doi: 10.3390/ijerph20010078
pmc: PMC9819479
pii:
doi:

Substances chimiques

Tobacco Smoke Pollution 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : R01-HL112212
Pays : United States

Références

Nicotine Tob Res. 2016 May;18(5):1282-1289
pubmed: 26508397
Int J Environ Res Public Health. 2018 Sep 20;15(10):
pubmed: 30241291
Nicotine Tob Res. 2015 Mar;17(3):316-22
pubmed: 25156526
Am J Health Promot. 2019 Jan;33(1):107-117
pubmed: 29772910
Health Educ Res. 2019 Apr 1;34(2):234-246
pubmed: 30624678
Int J Environ Res Public Health. 2021 Nov 29;18(23):
pubmed: 34886292
Am J Public Health. 2014 Aug;104(8):1445-53
pubmed: 24922124
Health Promot Pract. 2016 Nov;17(6):836-844
pubmed: 27402719
Am J Prev Med. 2013 Jan;44(1):63-6
pubmed: 23253651
Am J Public Health. 2017 Mar;107(3):380-383
pubmed: 28103063
Pediatrics. 2011 Jan;127(1):85-92
pubmed: 21149434
Health Place. 2019 Mar;56:106-117
pubmed: 30716667
Nicotine Tob Res. 2020 Dec 12;22(12):2254-2256
pubmed: 32080738
Indoor Air. 2015 Feb;25(1):13-20
pubmed: 24750252
Tob Control. 2009 Dec;18(6):438-44
pubmed: 19679890
Int J Environ Res Public Health. 2022 Mar 24;19(7):
pubmed: 35409538

Auteurs

Boram Lee (B)

Health Policy Research Center, Mongan Institute, Massachusetts General Hospital, Boston, MA 02114, USA.
Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, MA 02114, USA.
Harvard Medical School, Boston, MA 02115, USA.

Vicki Fung (V)

Health Policy Research Center, Mongan Institute, Massachusetts General Hospital, Boston, MA 02114, USA.
Harvard Medical School, Boston, MA 02115, USA.

David Cheng (D)

Harvard Medical School, Boston, MA 02115, USA.
Biostatistics Center, Massachusetts General Hospital, Boston, MA 02114, USA.

Jonathan P Winickoff (JP)

Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, MA 02114, USA.
Harvard Medical School, Boston, MA 02115, USA.
Division of General Academic Pediatrics, Massachusetts General for Children, Boston, MA 02114, USA.

Nancy A Rigotti (NA)

Health Policy Research Center, Mongan Institute, Massachusetts General Hospital, Boston, MA 02114, USA.
Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, MA 02114, USA.
Harvard Medical School, Boston, MA 02115, USA.
Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.

Radhika Shah (R)

Health Policy Research Center, Mongan Institute, Massachusetts General Hospital, Boston, MA 02114, USA.

Claire McGlave (C)

School of Public Health, University of Minnesota, Minneapolis, MN 55455, USA.

Sydney Goldberg (S)

Health Policy Research Center, Mongan Institute, Massachusetts General Hospital, Boston, MA 02114, USA.

Glory Song (G)

Office of Statistics and Evaluation, Bureau of Community Health and Prevention, Massachusetts Department of Public Health, Boston, MA 02108, USA.

Jacqueline Doane (J)

Massachusetts Tobacco Cessation and Prevention Program, Bureau of Community Health and Prevention, Massachusetts Department of Public Health, Boston, MA 02108, USA.

Melody Kingsley (M)

Office of Statistics and Evaluation, Bureau of Community Health and Prevention, Massachusetts Department of Public Health, Boston, MA 02108, USA.

Patricia Henley (P)

Massachusetts Tobacco Cessation and Prevention Program, Bureau of Community Health and Prevention, Massachusetts Department of Public Health, Boston, MA 02108, USA.

Sanouri Ursprung (S)

Office of Statistics and Evaluation, Bureau of Community Health and Prevention, Massachusetts Department of Public Health, Boston, MA 02108, USA.

Christopher Banthin (C)

Public Health Advocacy Institute, Northeastern University, Boston, MA 02115, USA.

Douglas E Levy (DE)

Health Policy Research Center, Mongan Institute, Massachusetts General Hospital, Boston, MA 02114, USA.
Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, MA 02114, USA.
Harvard Medical School, Boston, MA 02115, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH